Interviews

Episodes 1-11 of 11

• • 

    

    Prof. Ralf Gold

    Peer

  12

  

  RestartResume

  RestartResume

  SPECIAL REPORT: Expert Opinion on New MS Drug Approval
• 18

  

  RestartResume

  RestartResume

  Immunologic Effects on Metabolic Syndrome and MS
• 12

  

  RestartResume

  RestartResume

  Establishing Partnerships to Optimize Patient Outcomes
• 16

  

  RestartResume

  RestartResume

  Optimizing MS Treatment Options
• 13

  

  RestartResume

  RestartResume

  Highlights from the MAGNIMS Consensus Guidelines
• 22

  

  RestartResume

  RestartResume

  The Value of Biomarkers in MS Patients
• 25

  

  RestartResume

  RestartResume

  Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
• 27

  

  RestartResume

  RestartResume

  Emerging MRI Techniques in MS Patients
• 22

  

  RestartResume

  RestartResume

  Determining an MS Patient's Long-Term Prognosis
• 26

  

  RestartResume

  RestartResume

  Current Landscape of MS Diagnosis/Prognosis
• 30

  

  RestartResume

  RestartResume

  Current and Future MS Treatment Options